IRCT20200407046981N43尚未招募未知
Comparative bioequivalence study of the Ibrutinib 140 -mg Capsules manufactured by Noavaran Daroui Kimia Company with Ibrutinib brand capsules (Imbruvica®) by Janssen company
Kimia pharmaceutical Co0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Ibrutinib or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two week before dosing.
研究者
相似试验
招募中
Unknown
In-vivo Bioequivalence Study of Ibrutinib 140 mg capsule of The Test Drug (ACTLOUVIKA®, 140 mg , Actero Pharma, Iran)This study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200105046010N111Actro Middle East Pharmaceutical Co24
招募中
Unknown
Bioequivalence study of Ibrutinib 140 mgIRCT20200105046010N78Tabriz University of Medical Sciences24
进行中（未招募）
1 期
A study of Ibrutinib in Combination with Bortezomib and Dexamethasone in Multiple Myeloma PatientsEUCTR2015-005105-36-CZPharmacyclics Switzerland GmbH125
进行中（未招募）
1 期
A study of Ibrutinib in Combination with Bortezomib and Dexamethasone in Multiple Myeloma PatientsRelapsed or Relapsed and Refractory Multiple Myeloma (MM)MedDRA version: 19.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864EUCTR2015-005105-36-PLPharmacyclics Switzerland GmbH125
进行中（未招募）
1 期
A study of Ibrutinib in Combination with Bortezomib and Dexamethasone in Multiple Myeloma PatientsRelapsed or Relapsed and Refractory Multiple Myeloma (MM)MedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2015-005105-36-ITPHARMACYCLICS, INC.74